Alterations in EIF4A1 activity-modulating proteins expression have been observed in the tumourigenesis of melanoma (Joyce et al., 2017), breast cancer (Stoneley and Willis, 2015), and pancreatic cancer (Ma et al., 2019). The gene discussed is EIF4A1; the disease is breast cancer.